Dietary Lipids Modulate Notch Signaling and Influence Adult Intestinal Development and Metabolism in Drosophila
Developmental Cell,
Journal Year:
2018,
Volume and Issue:
47(1), P. 98 - 111.e5
Published: Sept. 13, 2018
Language: Английский
Oxysterols and nuclear receptors
Molecular and Cellular Endocrinology,
Journal Year:
2019,
Volume and Issue:
484, P. 42 - 51
Published: Jan. 18, 2019
Language: Английский
Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma
EMBO Molecular Medicine,
Journal Year:
2019,
Volume and Issue:
12(1)
Published: Nov. 28, 2019
Article28
November
2019Open
Access
Transparent
process
Therapeutic
implications
of
altered
cholesterol
homeostasis
mediated
by
loss
CYP46A1
in
human
glioblastoma
Mingzhi
Han
Shandong
Key
Laboratory
Brain
Function
Remodeling,
Department
Neurosurgery,
Qilu
Hospital
University
and
Institute
Brain-Inspired
Science,
University,
Jinan,
China
Biomedicine,
Bergen,
Norway
Search
for
more
papers
this
author
Shuai
Wang
orcid.org/0000-0002-0454-5281
Ning
Yang
Xu
Wenbo
Zhao
Halala
Sdik
Saed
Thomas
Daubon
INSERM
U1029,
Institut
Nationale
de
la
Santé
et
Recherche
Médicale,
Pessac,
France
Bordeaux,
Bin
Huang
Anjing
Chen
School
Medicine,
Gang
Li
Hrvoje
Miletic
Pathology,
Haukeland
Hospital,
Frits
Thorsen
orcid.org/0000-0002-7762-3703
The
Molecular
Imaging
Center,
Rolf
Bjerkvig
Corresponding
Author
[email
protected]
orcid.org/0000-0002-9622-7263
NorLux
Neuro-Oncology
Laboratory,
Oncology,
Luxembourg
Health,
City,
Xingang
orcid.org/0000-0002-0878-0211
Jian
orcid.org/0000-0002-9482-5227
Information
Han1,2,‡,
Wang1,‡,
Yang1,
Wang1,
Zhao1,
Saed2,
Daubon3,4,
Huang1,
Chen1,5,
Li1,
Miletic2,6,
Thorsen2,7,
*,2,8,‡,
*,1,‡
*,1,2,‡
1Shandong
2Department
3INSERM
4University
5School
6Department
7Department
8NorLux
‡These
authors
contributed
equally
to
work
as
senior
*Corresponding
author.
Tel:
+47
55586042;
E-mail:
+86
0537
82169428;
82169429;
EMBO
Mol
Med
(2020)12:e10924https://doi.org/10.15252/emmm.201910924
PDFDownload
PDF
article
text
main
figures.
Peer
ReviewDownload
a
summary
the
editorial
decision
including
letters,
reviewer
comments
responses
feedback.
ToolsAdd
favoritesDownload
CitationsTrack
CitationsPermissions
ShareFacebookTwitterLinked
InMendeleyWechatReddit
Figures
&
Info
Abstract
Dysregulated
metabolism
is
hallmark
many
cancers,
(GBM),
but
its
role
disease
progression
not
well
understood.
Here,
we
identified
24-hydroxylase
(CYP46A1),
brain-specific
enzyme
responsible
elimination
through
conversion
into
24(S)-hydroxycholesterol
(24OHC),
one
most
dramatically
dysregulated
genes
GBM.
was
significantly
decreased
GBM
samples
compared
with
normal
brain
tissue.
A
reduction
expression
associated
increasing
tumour
grade
poor
prognosis
gliomas.
Ectopic
suppressed
cell
proliferation
vivo
growth
24OHC
levels.
RNA-seq
revealed
that
treatment
cells
regulation
LXR
SREBP
signalling.
Efavirenz,
an
activator
known
penetrate
blood–brain
barrier,
inhibited
vivo.
Our
findings
demonstrate
critical
regulator
cellular
CYP46A1/24OHC
axis
potential
therapeutic
target.
Synopsis
Loss
partially
caused
excessive
accumulation
contributing
maintenance
viability
malignant
state.
anti-HIV
drug,
crosses
BBB
shows
anti-tumor
effect
though
activation
axis.
promotes
behavior
inhibits
via
catalyzing
production
24(S)-hydroxycholesterol.
has
favorable
penetration.
Drug
repurposing
Efavirenz
CYP46A1-24OHC
Introduction
Glioblastoma
(GBM)
common
primary
adults
(Fack
al,
2017;
Lhomond
2018).
Despite
aggressive
therapy,
maximal
surgical
resection
followed
radiotherapy
temozolomide
treatment,
median
patient
survival
14.6
months
from
initial
diagnosis
(Stupp
2005).
New
strategies
are
therefore
urgently
needed.
Emerging
evidence
linked
disrupted
cancer
development
(Bovenga
2015;
Kuzu
2016;
Cheng
However,
epidemiological
data
remain
contradictory
regarding
relationship
between
risk
serum
levels,
suggesting
circulating
levels
alone
have
marginal
effects
on
(Silvente-Poirot
Oxysterols
oxygenated
derivatives
participate
metabolism.
They
derived
diet
or
generated
endogenous
tissues.
include
24-hydroxycholesterol
25-hydroxycholesterol
(25OHC),
27-hydroxycholesterol
(27OHC)
ring
oxysterols
(Janowski
1996;
Berrodin
2010)
to,
addition
regulation,
modulate
signalling
pathways
such
Hedgehog,
Wnt
MAPK
(Kloudova
2017).
In
neurodegenerative
cancer,
interact
specific
proteins
transcription
factors,
liver
X
receptors
(LXR)
oxysterol-binding
protein
insulin-induced
gene
1
(INSIG1)
Recently,
it
been
shown
27OHC
can
inhibit
prostate
depletion
intracellular
(Alfaqih
Yet,
others
shown,
breast
cells,
induces
epithelial-to-mesenchymal
transition
(EMT)
leading
increased
(Torres
2011;
Wu
2013).
It
also
subtype
early-stage
hepatocellular
carcinoma
(Jiang
2019).
GBM,
notion
fuel
supported
following
evidence.
First,
novo
synthesis
astrocytes
exogenous
uptake
up-regulation
low-density
lipoprotein
receptor
(LDLR)
(Villa
2016).
Second,
leads
efflux
At
present,
mechanisms
causing
dysregulation
clear,
especially
regard
oxysterol
loss.
mammals,
tightly
regulated
complex
network
centred
around
two
groups
sterol-regulatory
binding
(SREBPs)
(LXRs),
involved
import,
export,
synthesis,
esterification
(Ikonen,
2008).
SREBPs
mainly
promote
genes,
HMGCR
LDLR,
when
decrease.
LXRs
respond
inducing
ABCA1
ABCG1,
LDLR
degradation
induction
E3
ubiquitin
ligase
IDOL
(Zelcer
2009).
Targeting
these
be
effective
strategy
inhibiting
animal
models
(An
Weiss,
Cancer
clearly
developed
order
support
their
growth.
Cholesterol
might
represent
key
factors
GBMs
unclear.
used
large-scale
silico
analyses
whole-transcriptome
databases
identify
homeostasis.
One
down-regulated
(24OHC)
(Moutinho
emerged
prognostic
marker
patients,
functional
studies,
overexpression
pharmacological
vitro
results
show
changes
targeting
may
provide
new
opportunity
therapy.
Results
level
determined
difference
brain.
Gene
set
enrichment
analysis
(GSEA)
based
Rembrandt
(n
=
217)
tissues
28)
displayed
distinct
metabolic
processes
(Appendix
Fig
S1A).
however,
positively
(adjusted
P
<
0.05,
respectively;
Appendix
S1A),
which
consistent
previous
reports
indicating
depend
synthesized
To
confirm
cholesterol,
lines
(LN229
U251)
GSCs
(GBM#P3)
were
cultured
media
FBS
lipoprotein-deficient
(LPDS).
Growth
curves
slower
LPDS
after
5
days
(P
0.01).
μg/ml
LDL
(the
highest
content)
medium
rescued
S1B–D).
These
importance
reported
previously
(Guo
Geng
suppressor
candidate
cholesterol-related
performed
bioinformatic
publicly
available
genomic
datasets.
signature
176
biology
Ontologies
Through
differential
using
dataset,
uncovered
total
13
differentially
expressed
tissue
(Fig
1A
B).
regulator,
CYP46A1,
(log2
fold
change
2.335,
adjusted
5.85E-25).
Differential
Chinese
Glioma
Genome
Atlas
(CGGA)
dataset
transcripts
1.966,
4.63E-09)
128)
5;
EV1A–C).
Univariate
Cox
regression
patients
screen
values.
After
ranking
P-value,
among
top
3
(APOBR,
CELA3A
CYP46A1)
EV1D).
By
analysing
(TCGA)
pan-cancer
31
different
types,
found
LGG
S2A).
further
confirmed
several
public
glioma
datasets
(over
1,500
enrolled;
0.01,
S2B).
Figure
1.
Expression
homeostasis,
lost
A.
Heatmap
glioblastomas
dataset.
values
z-transformed
coloured
red
high
blue
low
expression,
indicated
scale
bar.
B.
Volcano
plot
showing
(log2)
versus
Data
obtained
C.
Representative
images
IHC
staining
pathological
grades
gliomas
64).
Scale
bar
30
μm.
D.
Quantification
6)
58).
E.
adjacent
case.
F.
tumours
TCGA
2016
WHO
classification.
mean
±
standard
error
(SEM;
n
667).
***P
0.0001.
Statistical
significance
one-way
ANOVA.
G.
molecular
subtypes
Shown
means
SEM
245).
H–I.
Kaplan–Meier
OS
PFS
CGGA
P-values
log-rank
test.
Download
figure
PowerPoint
Click
here
expand
figure.
EV1.
correlates
strongly
features
5)
samples.
Venn
both
20
overall
intra-tumoral
pattern
IVY
(http://glioblastoma.alleninstitute.org/).
highly
at
edge
(which
comprised
cells)
other
regions
S2C).
Single-cell
(Darmanis
2017)
demonstrated
neurons,
oligodendrocyte
precursor
(OPCs)
lesser
extent
S2D).
examined
S2E).
Normal
(NHAs)
abundant
while
(GBM#P3,
GBM#05,
GBM#BG7,
LN229,
U251
LN18)
showed
much
lower
expression.
reduced
level,
independent
cohort
58)
6).
cytoplasmic.
consistently
(5/6;
88.3%)
(14/24;
58.3%)
(6/34;
17.6%),
1C
D).
sample
absent
1E).
Human
Protein
17)
corroborated
results,
confirming
EV2A),
EV2B
C).
EV2.
Decreased
high-grade
comparison
A–C.
quantification
provided
cerebellum,
cerebral
cortex
hippocampus,
4
low-grade
8
glioma).
200
scores
stained
estimated
each
type,
(not
detected
high),
intensity
(negative
strong),
quantity
>
75%)
sub-cellular
locations
positive
staining.
We
subsequently
assessed
classification
gliomas,
data.
higher
three
(LGG-Oligo,
LGG-Astro
LGG-IDHwt)
GBM-IDHmt
GBM-IDHwt
1F).
Although
there
general
down-regulation
brain,
observed
Neural
1G),
favourable
prognosis,
relative
Verhaak-2010
(Noushmehr
2010).
address
why
GBMs,
promoter/enhancer
combined
chromatin
immunoprecipitation
sequencing
(ChIP-seq)
GEO
ENCODE
databases.
H3K27ac
peaks
(marker
active
promoters)
within
promoter
region
S3A).
enhancer
landscape
across
matched
pairs
differentiated
(DGCs).
enhancers
mRNA
tended
decrease
GSC
DGC,
measured
ChIP-seq
(H3K27ac
H3K4me3
peak
levels)
S3A–C).
validated
ChIP-qPCR
Western
blot
S3D
E).
Taken
together,
abnormal
histone
modifications
explain
correlate
worse
determine
clinical
(based
value)
exhibited
better
(OS)
progression-free
(PFS)
1H
I).
indicator
value
TCGA,
Phillips
S4A–C).
univariate
multivariate
(HR
0.390,
95%
CI
0.262
0.581,
0.001;
Table
S1)
trend
patients.
Collectively,
emphasize
relevance
attenuates
Next,
vitro.
Lentivirus
over-express
LN18
GBM#P3,
qRT–PCR
2A)
2B
S5A).
Cell
lenti-CYP46A1
lenti-Ctrl
0.01;
2C).
attenuated
colony
formation
0.05;
2D).
Furthermore,
tumorsphere
formation,
stem-like
property
S5B
2.
Restoration
intracranial
xenografts
LN229
GBM#P3
transfected
lentivirus
expressing
(lenti-CYP46A1)
control
sequence
(lenti-Ctrl).
GAPDH
internal
control.
3).
LN229:
0.0001;
GBM#P3:
two-sided
Student's
t-test.
cells.
infected
trypan
**P
0.003;
0.002.
Colony-forming
assay
lenti-CYP46A1.
*P
0.013;
LN18:
0.012.
H&E
orthotopic
2
mm.
curve
tumour-bearing
mice
injected
per
group).
test
assess
statistical
significance.
PCNA
cleaved
caspase-3
tumours.
100
GBM#P3-lenti-CYP46A1
GBM#P3-lenti-control
intracranially
evaluate
For
growth,
haematoxylin
eosin
(HE)
2E),
prolonged
2F).
Overexpression
led
apoptotic
2G,
S5D
tumour-suppressive
encodes
cytochrome
P450
oxidase,
sterol
24-hydroxylase,
function
convert
3A).
characterized
3)
S6A).
Language: Английский
LDL, HDL and endocrine-related cancer: From pathogenic mechanisms to therapies
Seminars in Cancer Biology,
Journal Year:
2020,
Volume and Issue:
73, P. 134 - 157
Published: Nov. 26, 2020
Language: Английский
Impact of Oxysterols on Cell Death, Proliferation, and Differentiation Induction: Current Status
Cells,
Journal Year:
2021,
Volume and Issue:
10(9), P. 2301 - 2301
Published: Sept. 3, 2021
Oxysterols
are
oxidized
derivatives
of
cholesterol
produced
by
enzymatic
activity
or
non-enzymatic
pathways
(auto-oxidation).
The
oxidation
processes
lead
to
the
synthesis
about
60
different
oxysterols.
Several
oxysterols
have
physiological,
pathophysiological,
and
pharmacological
activities.
effects
on
cell
death
processes,
especially
apoptosis,
autophagy,
necrosis,
oxiapoptophagy,
as
well
their
action
proliferation,
reviewed
here.
These
effects,
also
observed
in
several
cancer
lines,
could
potentially
be
useful
treatment.
differentiation
described.
Among
them,
properties
stimulating
osteogenic
mesenchymal
stem
cells
while
inhibiting
adipogenic
may
regenerative
medicine.
Language: Английский